Metabolism-based
Cancer Therapy Symposium 2022

Wednesday, November 30, 2022・ONLINE

In the last decade cancer metabolism has emerged as a cancer hallmark. Although it has been almost a century since Otto Warburg described a difference in cellular metabolism in cancer cells, cancer-specific metabolic alterations have not been fully exploited therapeutically. Increasing numbers of studies showed both the complexity and the promise of targeting metabolism as a therapeutic strategy in cancer. It is time for scientists and clinicians working on this strategy to meet and exchange their experience.

With a translational focus, the symposium brings together oncologists and researchers interested in exploiting the metabolic bias of tumors for therapeutic interventions. It aims to shed light and bring to discussion novel translational approaches that are either currently under clinical testing or show translational potential in preclinical studies.  

Organizing Team

Dr. Mohamed Elgendy, Institute for Clinical Chemistry, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
Dr. med. Ekaterina Balaian, Medical Clinic 1, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
Prof. Martin Bornhäuser, Medical Clinic 1, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
Prof. Dr. med. Triantafyllos Chavakis, Institute for Clinical Chemistry, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden
Dr. Peggy Jungke, Scientific and Event coordination at Mildred Scheel Early Career Center Dresden

Session 1

12:45–13:00 CET
Welcoming remarks
Ekaterina Balaian, Dresden, Germany
Mohamed Elgendy, Dresden, Germany

13:00–13:30 CET
Targeting mitochondria in oxidative lung tumors
Rodrigue Rossignol, Bordeaux, France

13:30–14:00 CET
Metabolic modulation of tumors with engineered bacteria for immunotherapy
Roger Geiger, Bellinzona, Switzerland

14:00–14:15 CET
Open discussion


Break 

Session 2

14:45–15:15 CET
Targeting the extrinsic regulation of stem cell metabolism in the myeloproliferative neoplasms
Simón Méndez-Ferrer, Cambridge, UK

15:15–15:45 CET
Taking control of innate immunity with nanotherapeutics
Willem Mulder, Eindhoven, The Netherlands

15:45–16:15 CET
The role of lactic acid for leukemia immune escape after allogeneic stem cell transplantation
Robert Zeiser, Freiburg, Germany

16:15–16:45 CET
Translation-based sensing of glutamine availability regulates cell fate and function within the tumor microenvironment
Natalya Pavlova, Salt Lake City, USA

16:45–17:15 CET
Open discussion

17:30 CET
OUTLOOK

 

Roger Geiger, PhD
Institute for Research in Biomedicine
Via Francesco Chiesa 5
6500 Bellinzona, Switzerland

Willem Mulder, PhD
Eindhoven University of Technology
Laboratory of Chemical Biology
Het Kranenveld 14
5612 AZ Eindhoven, The Netherlands

Natalya Pavlova, PhD
Department of Oncological Sciences
Huntsman Cancer Institute
University of Utah School of Medicine
2000 Circle of Hope Drive
Salt Lake City, UT 84112, USA

Rodrigue Rossignol, PhD
INSERM U1211 Rare Diseases, Genetics and Metabolism
University of Bordeaux
CHU Pellegrin
Place Amélie Raba Léon, Ecole des Sages Femmes, étage 2
33000 Bordeaux, France

Simón Méndez-Ferrer, Prof.
Department of Haematology
Jeffrey Cheah Biomedical Centre
Puddicombe Way
Cambridge Biomedical Campus
CB2 0AW, UK

Robert Zeiser, Prof. Dr.
Tumorimmunologie und Immunregulation
Klinik für Innere Medizin I
Universitätsklinikum Freiburg
Hugstetter Str. 55
79106 Freiburg, Germany

Scientific administration

Dr. med. Ekaterina Balaian, Medical Clinic 1, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden

Dr. Mohamed Elgendy, Institute for Clinical Chemistry, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden

Prof. Martin Bornhäuser, Medical Clinic 1, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden

Prof. Dr. med. Triantafyllos Chavakis, Institute for Clinical Chemistry, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden

Organizer

GWT-TUD GmbH
Freiberger Straße 33
01067 Dresden

Conference time

Wednesday, November 30, 2022・ONLINE
12am until 6pm

Broadcast

via Zoom

Continuing Medical Education Credits (CME)

The CME credits have been applied for at the Saxon State Medical Association. We expect approx. 4 continuing medical education credits.

Felix Manthei
Projektmanager

Mobile: +49 163 250 72 07
Phone: +49 351 25 933 210

GWT-TUD GmbH
Fachbereich Medizin

BioInnovationsZentrum
Tatzberg 47/49
01307 Dresden

Deutsche Krebshilfe und Mildred-Scheel-Nachwuchszentrum Dresden (600,- €)

Novarts Pharma AG (500,- €)

Metabolism-based Cancer Therapy Symposium 2021

8th October 2021, Dresden

Bildnachweis: Graphic elements designed by Freepik